Related Experiment Video
Updated: Jan 21, 2026

Systemic Bacterial Infection and Immune Defense Phenotypes in Drosophila Melanogaster
Published on: May 13, 2015
Bacterial Translocation and Host Immune Activation in Chronic Hepatitis C Infection
Mi Sun Moon1, Gabriella Quinn1, Elizabeth C Townsend1
1Translational Hepatology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Insights
Bacterial translocation in Hepatitis C virus (HCV) infection involves distinct microbial components. Hepatic macrophage uptake, not just circulating markers, may better indicate immune activation in chronic HCV patients.
Area of Science:
- Hepatology
- Immunology
- Microbiology
Background:
- Hepatitis C virus (HCV) infection affects millions globally, with persistent treatment barriers.
- Bacterial translocation is a known complication in chronic HCV, impacting host immunity.
- Understanding microbial components and immune responses is crucial for managing HCV.
Purpose of the Study:
- To evaluate circulating microbial components (lipopolysaccharide, peptidoglycan, β-D-glucan) in HCV patients.
- To assess pattern recognition receptors and hepatic macrophage uptake of these microbial components.
- To elucidate the relationship between bacterial translocation and host immune activation in HCV.
Main Methods:
- Quantification of serum lipopolysaccharide, peptidoglycan, and β-D-glucan.
- Analysis of pattern recognition receptor expression.
- Assessment of microbial component uptake by hepatic macrophages.
Main Results:
- Serum peptidoglycan and β-D-glucan regulation differs from lipopolysaccharide.
- Hepatic macrophage uptake correlates with immune activation more than circulating microbial levels.
- Distinct patterns of microbial component translocation observed in HCV.
Conclusions:
- Hepatic macrophage uptake is a key indicator of immune activation in HCV.
- Findings enhance understanding of bacterial translocation mechanisms in chronic HCV.
- Potential for novel therapeutic targets by modulating immune responses to bacterial translocation.
Abstract:
Hepatitis C virus (HCV) infects 71 million individuals, and barriers to treatment remain. Bacterial translocation is a complication of chronic HCV infection, and this study evaluated circulating microbial components including lipopolysaccharide, peptidoglycan, and β-D-glucan in addition to their pattern recognition receptors and degree of hepatic macrophage uptake. The findings suggest that regulation of serum peptidoglycan and β-D-glucan differs from that of lipopolysaccharide. Additionally, macrophage activation in the liver may be better reflected by the degree of macrophage uptake than by circulating levels of microbial markers. These findings allow for a greater understanding of bacterial translocation and host immune activation during HCV infection.
Related Concept Videos
Bacterial Translocation and Protein Secretion
Humoral Immune Responses
What is the Immune System?
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...

